Nancy Belcher, PhD, is a scientist, healthcare innovator, and policy leader whose career bridges molecular biology, public health, and medical advocacy. Trained as a biochemist with research at the University of Pennsylvania and Fred Hutchinson Cancer Center, her work focused on cell-to-cell communication and genetic regulation. After witnessing how political decisions could abruptly shutter research labs, she transitioned into health policy to champion evidence-based practice, equitable access, and sustainable healthcare systems. Nancy is the co-founder of Winona, a national telehealth company dedicated to improving women’s health through accessible, evidence-based hormone therapy and personalized care. She also leads transformative initiatives in cancer treatment access, hemophilia education, and health equity, including Pfizer-funded programs that create clinician training, shared decision-making tools, and community-focused resources. As CEO of the King County Medical Society, Nancy drives system-level reforms, strengthens physician engagement, and advances policies that improve patient outcomes. Her career combines scientific rigor, practical innovation, and a deep commitment to public health—building solutions that support clinicians, patients, and communities with clarity, compassion, and integrity.